The Nordic Chronic Migraine Trial of CGRP Monoclonal Antibody and Onabotulinumtoxin A Dual Therapy Compared to CGRP mAbs Monotherapy
Abroad (travel likely)RecruitingPHASE3
Conditions
Migraine · Chronic Migraine Headache
Simple summaryAI-assisted
This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.
Locations
Østfold Hospital Trust, Grålum, Norway
Contact: Principal Investigator (Zhilwan Gadan, MD)Sørlandet Hospital Kristiansand, Kristiansand, Norway
Contact: Principal Investigator (Kai Ivar Müller, MD PhD)Innlandet Hospital Trust Lillehammer, Lillehammer, Norway
Contact: Study coordinator (Mari Aalstad-Johansen, MD) · Mari.Aalstad@sykehuset-innlandet.no · +47 91 50 62 00Contact: Principal Investigator (Mari Aalstad-Johansen, MD)Oslo University Hospital, Oslo, Norway
Contact: Study coordinator (Anne Hege Aamodt, MD PhD Prof) · a.h.aamodt@medisin.uio.no · +47 23 07 00 00Contact: Principal Investigator (Anne Hege Aamodt, MD PhD Prof)Burcu Bezgal, MD (Sub-investigator)Telemark Hospital Trust Skien, Skien, Norway
Contact: Study coordinator (Christoffer Haugen Melbye, MD) · Christoffer.Haugen.Melbye@sthf.no · +47 35 00 35 00Contact: Study coordinator (Heidi Øyen Flemmen, MD PhD)Contact: Principal Investigator (Christoffer Haugen Melbye, MD)St. Olav University Hospital, Trondheim, Norway
Contact: Principal Investigator (Kristin Wesnes, MD PhD)